Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...

A naturally occurring enzyme called hyaluronidase may be an effective alternative treatment for spasticity, or muscle stiffness, a disabling condition in people who have had a stroke or other brain ...

New Delhi, June 04, 2024 (GLOBE NEWSWIRE) -- The global hyaluronidase market exhibited a valuation of US$ 852.0 million in 2023, and it is projected to reach a market valuation of US$ 1,896.8 million ...

Amsterdam, the Netherlands—June 20, 2023—argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...

Tergase® is a stand-alone hyaluronidase product that can be used for the treatment of various medical conditions, such as pain relief, edema treatment, and hyaluronic acid filler removal. In ...

Alteogen expects Tergase ® will replace commercially available animal-derived hyaluronidase products and their significant disadvantages. Compared with other commercially available hyaluronidase ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...